Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with mild Alzheimer's disease and have scored between 21 and 30 on a standard memory and thinking test called the Mini Mental State Examination
- People who have a family member or carer available to help fill out questionnaires, thinking and memory scales, and sleep diaries
- People who are already receiving, or are scheduled to receive, a neurological assessment that includes blood tests and a spinal fluid sample (taken via a procedure called a lumbar puncture) for diagnostic purposes
- People who have had a lumbar puncture within the last year, or who have one already planned as part of their medical care
- People who have signed a form giving their informed consent to take part
- People who are able to attend all required visits and follow the study procedures
- People who are enrolled in the French social security system
Who may not be able to join:
- People who have a genetic (inherited) form of Alzheimer's disease
- People whose medical information is not sufficient to confirm an Alzheimer's disease diagnosis
- People who are currently taking anticholinesterase or memantine medications, unless they have been on a stable dose for at least 3 months (confirm with trial site)
- People who have used antidepressants, anti-anxiety medications, sleeping pills, or antipsychotic medications in the 15 days before joining the trial
- People who are currently living in a nursing home
- People who are unable to read or cannot complete thinking and behavioural tests
- People who have significant physical or sensory difficulties that could interfere with the tests
- People for whom a lumbar puncture is medically not suitable — for example, due to previous spinal surgery, a skin infection at the puncture site, blood clotting problems, increased pressure in the brain, severe liver problems, or certain blood-thinning medications
- People who do not wish to have a lumbar puncture
- People for whom the temperature-monitoring device used in the study (called E-Celsius, a small swallowable capsule) is not suitable — this includes people who weigh less than 40 kg, have bowel disorders, or have known difficulty swallowing
- People who are currently under legal detention or restricted freedom by a court or administrative decision
- People who are legally protected adults under French law
- People who are currently participating in another clinical trial that restricts participation, or who have already received the maximum allowed study compensation of €4,500 in the current year
- People who do not wish to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karim BENNYS, MD, University Hospital, Montpellier
Phone: +33467333162
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the Free and Cued Selective Reminding Test (FCSRT) scale score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.